NCT00988507 - Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter

Enrollment

440

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Plasmodium Falciparum Infection

Interventions

DRUG

Ferroquine (SSR97193)

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

Placebo

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

artesunate

"Pharmaceutical form: tablets~Route of administration: oral"

Trial Locations (10)

Sanofi-Aventis Investigational Site Number 204001, Cotonou

Sanofi-Aventis Investigational Site Number 854002, Bobo-Dioulasso

Sanofi-Aventis Investigational Site Number 854003, Nouna

Sanofi-Aventis Investigational Site Number 854001, Ouagadougou

Sanofi-Aventis Investigational Site Number 120001, Yaoundé

Sanofi-Aventis Investigational Site Number 266001, B.P. 118 Lambarene

Sanofi-Aventis Investigational Site Number 266002, Libreville

Sanofi-Aventis Investigational Site Number 404001, Kilifi

Sanofi-Aventis Investigational Site Number 404002, Kisumu

Sanofi-Aventis Investigational Site Number 834001, Korogwe